Benefits of Telephone Care Over Primary Care for Smoking Cessation

An, Lawrence C.; Zhu, Shu Hong; Nelson, David B.; Arikian, Nancy J.; Nugent, Sean; Partin, Melissa R.; Joseph, Anne M.

doi:10.1001/archinte.166.5.536

Cited by 72 publications

(60 citation statements)

References 37 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…29 Another study using cellular telephones for counseling among HIV-positive smokers increased cessation rates to 37% compared to 10% in the usual care group, 28 results that are very similar to a study of HIV-negative patients utilizing telephone intervention. 30 Our data suggest that efforts to improve smoking cessation rates should include increased education and training of HIV providers to detect smoking and counsel smoking cessation, as HIV providers reported less confidence in their ability to influence their patients to stop smoking than non-HIV providers. These results are parallel to an earlier report that found that ID-certified physicians were less comfortable with prescribing medications to their HIV-positive patients for hyperlipidemia, diabetes, hypertension, and depression than GM-certified physicians to their patients.…”

Section: Discussionmentioning

confidence: 73%

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

et al. 2007

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 73%

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

et al. 2007

View full text Add to dashboard Cite

“…Finally, we found that PFT is likely underused in these symptomatic, high-risk patients with HIV infection. The HIV population may be more susceptible to diseases, such as COPD and lung cancer, and to mortality associated with smoking (7,8,12,(52)(53)(54)(55)(56)(57), and smoking cessation counseling is of great importance in this population.…”

Section: Discussionmentioning

confidence: 99%

Pulmonary Function Abnormalities in HIV-Infected Patients during the Current Antiretroviral Therapy Era

Gingo¹,

George²,

Kessinger³

et al. 2010

Am J Respir Crit Care Med

188

237

View full text Add to dashboard Cite

Rationale: Before the introduction of combination antiretroviral (ARV) therapy, patients infected with HIV had an increased prevalence of respiratory symptoms and lung function abnormalities. The prevalence and exact phenotype of pulmonary abnormalities in the current era are unknown. In addition, these abnormalities may be underdiagnosed. Objectives: Our objective was to determine the current burden of respiratory symptoms, pulmonary function abnormalities, and associated risk factors in individuals infected with HIV. Methods: Cross-sectional analysis of 167 participants infected with HIV who underwent pulmonary function testing. Measurements and Main Results: Respiratory symptoms were present in 47.3% of participants and associated with intravenous drug use (odds ratio [OR] 3.64; 95% confidence interval [CI], 1.32-10.046; P 5 0.01). Only 15% had previous pulmonary testing. Pulmonary function abnormalities were common with 64.1% of participants having diffusion impairment and 21% having irreversible airway obstruction. Diffusion impairment was independently associated with ever smoking (OR 2.46; 95% CI, 1.16-5.21; P 5 0.02) and Pneumocystis pneumonia prophylaxis (OR 2.94; 95% CI, 1.10-7.86; P 5 0.01), whereas irreversible airway obstruction was independently associated with pack-years smoked (OR 1.03 per pack-year; 95% CI, 1.01-1.05; P , 0.01), intravenous drug use (OR 2.87; 95% CI, 1.15-7.09; P 5 0.02), and the use of ARV therapy (OR 6.22; 95% CI, 1.19-32.43; P 5 0.03). Conclusions: Respiratory symptoms and pulmonary function abnormalities remain common in individuals infected with HIV. Smoking and intravenous drug use are still important risk factors for pulmonary abnormalities, but ARV may be a novel risk factor for irreversible airway obstruction. Obstructive lung disease is likely underdiagnosed in this population.Keywords: HIV; respiratory function tests; smoking; antiretroviral therapy, highly active; AIDS Pulmonary complications have been a major cause of morbidity and mortality in patients with HIV infection (1, 2). With the development of combination antiretroviral (ARV) therapy and improvements in prophylaxis for Pneumocystis pneumonia (PCP) and other opportunistic infections, the incidence of infectious pulmonary complications has decreased drastically in patients with HIV infection (1, 3, 4). Changes in noninfectious pulmonary complications, such as chronic obstructive pulmonary disease (COPD) and asthma, are less clear, and these diseases may actually be increasing. Studies before the introduction of combination ARV demonstrated that persons with HIV infection had a higher prevalence of impaired diffusing capacity for carbon monoxide (DL CO ), increased emphysema, accelerated airway obstruction and small airways disease, and more frequent respiratory symptoms than subjects not infected with HIV (2, 5-8).Limited data exist regarding the extent and types of pulmonary function abnormalities in the current era. In one recent study, veterans with HIV infection had an increased risk of COPD compared wi...

show abstract

“…3 Also smokers with psychiatric comorbidities may benefit from combined pharmacotherapy and behavioral counseling with longer therapeutic approaches (i.e., exceeding 8-12 weeks) to reduce likelihood of dropout and depression relapse. 16,[53][54][55] Future research should be designed to optimize dose, duration, sequencing, and frequency of both behavioral counseling and pharmacotherapies.…”

Section: Future Researchmentioning

confidence: 99%

Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis

et al. 2011

View full text Add to dashboard Cite

OBJECTIVES:We conducted a systematic literature review of smoking cessation interventions for patients with histories of depressive disorders or current significant depressive symptoms. We examined the comparative effectiveness of smoking cessation strategies on abstinence rates, differential effects of cessation strategies by depression status (i.e., history positive vs. current depression), and differential effects by gender. DATA SOURCES: Peer-reviewed literature in MEDLINE, Embase, PsycINFO, and Cochrane Library. STUDY ELIGIBILITY CRITERIA, PARTICIPANTS, AND INTERVENTIONS: Randomized controlled trials or secondary analysis of RCT data comparing two or more smoking cessation interventions or intervention to control, and reporting cessation outcomes in adults with depression. STUDY APPRAISAL AND SYNTHESIS METHODS: Two trained researchers screened articles for inclusion. When possible, we estimated pooled risk ratios with 95% confidence intervals by using a random effects model with the Mantel-Haenszel method. We synthesized other studies qualitatively. We classified each intervention as antidepressants, nicotine replacement therapy (NRT), brief smoking cessation counseling, smoking cessation behavioral counseling, or behavioral mood management. RESULTS: We identified 16 unique RCTs, of which, only three trials recruited participants with current depression. Meta-analysis demonstrated a small, positive effect of adding behavioral mood management (RR = 1.41, 95% CI 1.01-1.96). All included antidepressant trials showed small, positive effects, but risk ratio summary was not significant (RR = 1.31, 95% CI 0.73-2.34). Three NRT trials demonstrated small, positive effects on smoking cessation rates. We found insufficient evidence to examine gender and depression status moderator effects. LIMITATIONS: Few RCTs exist that test smoking cessation interventions among adults with depression. To make meaningful comparisons, we created broad intervention categories that contained heterogeneity. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS:Few trials enrolled smokers with current depression. Most of data identified were from subgroup analyses of patients history-positive for depression. However, several promising interventions exist. Healthcare providers should consider encouraging their patients with significant depressive symptoms or depression histories to seek smoking cessation services that include NRT and behavioral mood management.

show abstract

Benefits of Telephone Care Over Primary Care for Smoking Cessation

Cited by 72 publications

References 37 publications

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

Decreased Awareness of Current Smoking Among Health Care Providers of HIV-positive Compared to HIV-negative Veterans

Pulmonary Function Abnormalities in HIV-Infected Patients during the Current Antiretroviral Therapy Era

Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysis

Contact Info

Product

Resources

About